Bayer is investing $2.2 billion in a new production site in Ohio
Quick Look
Bayer plans to invest $2.2 billion in a new production site in New Albany, Ohio, to combine the production of active pharmaceutical ingredients and finished drugs and create around 600 highly qualified jobs.
AI-generated summary
Why It Matters
Bayer has invested more than $7 billion in pharmaceutical research, development and production in the United States over the past five years.
The pharmaceutical and agrochemical group Bayer wants to invest 2.2 billion US dollars (1.95 billion euros) in a new production site in the United States. This is expected to create around 600 highly qualified jobs in New Albany, Ohio, the company announced. The aim is to combine the production of active pharmaceutical ingredients and finished medicinal products at one location.
“The United States has long been an important production location and an important innovation center for Bayer,” said CEO Bill Anderson. “At the new location, we bring together manufacturing expertise and qualified specialists to provide patients in the United States and worldwide with innovative, high-quality medicines.”
Bayer has invested more than seven billion dollars in pharmaceutical research and development and production in the USA over the past five years.
What to Watch
AI outlook — possibilities, not facts
The new production facility will improve Bayer's ability to deliver in North America.
Likely · Within months
Open Questions
- When exactly will production start at the new location?
- What specific medicines are manufactured there?
